Neuropeptide Y and CRH in Major Depressive Disorder (MDD)

被引：0
|
作者：
Mathe, Aleksander A. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 2013年 / 17卷
关键词：
CORTICOTROPIN-RELEASING HORMONE; CEREBROSPINAL-FLUID; RAT;
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [31] Blunted d-amphetamine response in major depressive disorder (MDD).
    Tremblay, LK
    Naranjo, CA
    Busto, U
    Cardenas, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 141 - 141
  • [32] The dex/CRH test and the DST in patients with bipolar disorder and major depressive disorder
    Watson, Stuart
    Gallagher, Peter
    Smith, Margaret S.
    Ferrier, I. Nicol
    Young, Allan H.
    PSYCHONEUROENDOCRINOLOGY, 2007, 32 (01) : 92 - 94
  • [33] Adjunctive aripiprazole in major depressive disorder (MDD): efficacy and predictors of remission
    Nelson, J. C.
    Thase, M. E.
    Baker, R. A.
    Rollin, L. M.
    McQuade, R. D.
    Marcus, R. N.
    Berman, R. M.
    Wisniewski, S. R.
    Gismondi, R.
    Loze, J. Y.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S386 - S386
  • [34] Longitudinal assessment of sleep neurophysiology in adolescent major depressive disorder (MDD)
    Castiglione, Chiara
    Markovic, Andjela
    Wild, Salome
    Zarafeta, Dimitra
    Kaess, Michael
    Tarokh, Leila
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [35] ECONOMIC ANALYSIS OF ESCITALOPRAM (GENERIC DRUG) IN MAJOR DEPRESSIVE DISORDER (MDD)
    Walczak, J.
    Nogas, G.
    Garbacka, M.
    Obrzut, G.
    Pieniazek, I
    VALUE IN HEALTH, 2010, 13 (03) : A114 - A114
  • [36] Efficacy and safety of sertraline in the treatment of pediatric major depressive disorder (MDD)
    Wagner, K
    Donnelly, C
    Wohlberg, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S231 - S232
  • [37] Major depressive disorder (mdd): emerging immune targets at preclinical level
    Varma, Manasi
    Kaur, Arshpreet
    Bhandari, Ranjana
    Kumar, Ashwani
    Kuhad, Anurag
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2023, 27 (06) : 479 - 501
  • [38] COST AND RESOURCE USE OF MANAGING MAJOR DEPRESSIVE DISORDER (MDD) IN CHINA
    Low, W.
    Azmi, S.
    Yee, S. L.
    Abdat, A.
    Yang, Y.
    Milea, D.
    VALUE IN HEALTH, 2014, 17 (07) : A768 - A769
  • [39] Major depressive disorder (MDD) in adolescents with Borderline (BPD) and Shyzotypal personality disorder (STPD)
    Kaleda, V.
    Krylova, E.
    Kuleshov, A.
    EUROPEAN PSYCHIATRY, 2023, 66 : S747 - S747
  • [40] Subgenual Anterior Cingulate Cortex Volume in Major Depressive Disorder (MDD) - Influence of MDD Onset Age
    Jaworska, Natalia
    Yang, Xiao-Ru
    MacMaster, Frank
    Ramasubbu, Rajamannar
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 192S - 192S
12345